Analyst Coverage
Dr. Richard Timmer
Tekmira Pharmaceuticals Corporation is followed by the firms and analysts listed above. This list, including the firms and individual analyst(s) at these firms, is subject to change at any time without notice, and this list may not reflect the most current list of firms and analysts providing coverage of Tekmira.
Tekmira makes no representations or warranties as to the accuracy of any information contained herein and expressly disclaims any obligation to update such information. Please note that any opinions, estimates, forecasts, conclusions or recommendations regarding Tekmira made by these analysts on behalf of their respective firms are theirs alone and do not represent opinions, estimates, forecasts, conclusions or recommendations of Tekmira or its management. Tekmira does not by its reference above or in any other manner imply its endorsement of or concurrence with any such opinions, estimates, forecasts, conclusions or recommendations.
Loewen, Ondaatje, McCutcheon Limited
416.964.4430
Dr. David Martin
Dundee Securities
416.350.3477
Mr. Pooya Hemami
Desjardins Securities
514.985.7574
Dr. Doug Loe
Versant Partners
416.849.5005
